Portal de recerca
Estudio no intervencionista retrospectivo para desarrollar un modelo de IA basado en imágenes para la predicción de la recurrencia metastásica en pacientes con cáncer de próstata localizado. Estudio PROVIDENCE.
Dades bàsiques
- Protocol:
- 56021927PCR4032
- EURDRACT:
- NCT:
- Centre:
- HOSPITAL UNIVERSITARI I POLITÈCNIC LA FE
- Any inici:
- 2023
- Any de finalització:
Documents
- No hi ha documents
Participants
Grups d'Investigació
Finançadors - Promotors
Resultats de l'Assaig Clínic
A Phase II Trial of Stereotactic Body Radiation Therapy and Androgen Deprivation for Oligometastases in Prostate Cancer (SBRT-SG 05).
Conde-Moreno, Antonio J; (...); Ferrer, Carlos
Article. 10.1016/j.prro.2024.04.022. 2024
A randomised trial of short- vs long-term androgen deprivation with salvage radiotherapy for biochemical failure following radical prostatectomy: URONCOR 06-24.
González-San Segundo C; (...); Couñago F
Article. 10.1111/bju.16484. 2024
A Smart Digital Health Platform to Enable Monitoring of Quality of Life and Frailty in Older Patients with Cancer: A Mixed-Methods, Feasibility Study Protocol.
Papachristou, Nikolaos; (...); Bamidis, Panagiotis D.
Article. 10.1016/j.soncn.2023.151437. 2023
Amyloid brain-dedicated PET images can diagnose Alzheimer's pathology with Centiloid Scale.
Gandia-Ferrero MT; (...); Martí-Bonmatí L
Article. 10.1016/j.ejmp.2024.103345. 2024
Bladder cancer patients have increased NETosis and impaired DNaseI-mediated NET degradation that can be therapeutically restored in vitro.
Article. 10.3389/fimmu.2023.1171065. 2023
Brachytherapy for targeting the immune system in cervical cancer patients.
Linares I; (...); Pujol M
Article. 10.1186/s12865-023-00559-y. 2023
Correction to: Radiation therapy for vulvar cancer: consensus guidelines of the GINECOR working group of the Spanish Society of Radiation Oncology. Part 1: clinical recommendations.
Cordoba Largo S; (...); Sánchez Belda M
Correction. 10.1007/s12094-023-03183-9. 2023
Encorafenib and binimetinib followed by radiotherapy for patients with BRAFV600-mutant melanoma and brain metastases (E-BRAIN/GEM1802 phase II study).
Marquez-Rodas, Ivan; (...); Berrocal, Alfonso
Article. 10.1093/neuonc/noae116. 2024
Evaluation of EMBARK criteria patients. Real-world data on prostate cancer biochemical recurrence
Centelles Hidalgo, Elena; (...); Lopez-Campos, Fernando
Meeting Abstract. 2024
LATTICE radiotherapy: A one institution experience
Solero, I.; (...); Conde, A.
Meeting Abstract. 2023
Multi-Institutional Analysis of Metastasis Directed Therapy with or without Androgen Deprivation Therapy in Oligometastatic Castration Sensitive Prostate Cancer.
Sutera, P.; (...); Sweeney, C.
Article. 10.1016/j.ijrobp.2023.06.1620. 2023
Multi-institutional Analysis of Metastasis-directed Therapy with or Without Androgen Deprivation Therapy in Oligometastatic Castration-sensitive Prostate Cancer.
Deek MP; (...); Sweeney C
Article. 10.1016/j.euo.2024.03.010. 2024
Node Oligorecurrence in Prostate Cancer: A Challenge.
Zapatero A; (...); Aldave D
Article. 10.3390/cancers15164159. 2023
Objective Image Quality Comparison Between Brain-Dedicated PET and PET/CT Scanners.
Gandia-Ferrero MT; (...); Martí-Bonmatí L
Article. 10.1007/s10916-023-01984-7. 2023
Oxygen therapy at 1.4 atmospheres in radiation-induced cystitis and proctitis
Prato Carreno, O. A.; (...); Conde Moreno, A. J.
Meeting Abstract. 2023
PEACE V-Salvage Treatment of oligorecurrent nodal prostate cancer metastases (STORM): 24-months toxicity results of a randomized phase II trial
Zilli, T.; (...); Ost, P.
Meeting Abstract. 2024
PEACE V-Salvage Treatment of OligoRecurrent nodal prostate cancer Metastases (STORM): Acute Toxicity of a Randomized Phase 2 Trial.
Ost, Piet; (...); Zilli, Thomas
Article. 10.1016/j.euo.2023.09.007. 2023
Real-world evidence analysis of early-stage prostate cancer using natural language processing
Juarez, Alvaro; (...); Alcaraz, Antonio
Meeting Abstract. 2023
Re-irradiation in NSCLC High-dose RT: Control, Survival and Toxicity
Germain, J.; (...); Conde, A.
Meeting Abstract. 2023
Relationship between neuroimaging and emotion recognition in Mild Cognitive Impairment patients.
Gandia-Ferrero, Maria Teresa; (...); Marti-Bonmati, Luis
Article. 10.1016/j.bbr.2023.114844. 2024
RT after Encorafenib and Binimetinib on BRAF mutated melanoma brain metastases. GEM1802-Phase II
Alvarez, A.; (...); Marquez Rodas, I.
Meeting Abstract. 2023
Salvage Treatment of OligoRecurrent nodal prostate cancer Metastases (STORM)
Ost, Piet; (...); Moon, Daniel
Meeting Abstract. 2024
Spinocerebellar Ataxia 36 is a Frequent Cause of Hereditary Ataxia in Eastern Spain
Baviera-Munoz, Raquel; (...); Bataller, Luis
Article. 10.1002/mdc3.13740. 2023
Validation of urine p-cresol glucuronide as renal cell carcinoma non-invasive biomarker
Oto, Julia; (...); Medina, Pilar
Article. 10.1016/j.jprot.2024.105357. 2025